Evarrest

RSS

human fibrinogen / human thrombin

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Evarrest has been withdrawn at the request of the marketing-authorisation holder.

This EPAR was last updated on 03/04/2018

Authorisation details

Product details
Name
Evarrest
Agency product number
EMEA/H/C/002515
Active substance
  • human fibrinogen
  • human thrombin
International non-proprietary name (INN) or common name
human fibrinogen / human thrombin
Therapeutic area (MeSH)
Hemostasis
Anatomical therapeutic chemical (ATC) code
B02BC30
Additional monitoring

This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.

Publication details
Marketing-authorisation holder
Omrix Biopharmaceuticals N. V.
Revision
4
Date of issue of marketing authorisation valid throughout the European Union
25/09/2013
Contact address
Leonardo Da Vinci Laan 15
1831 Diegem
Belgium

Product information

15/11/2017 Evarrest - EMEA/H/C/002515 - II/0027/G

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Haemostatic combinations

Therapeutic indication

Supportive treatment in adult surgery where standard surgical techniques are insufficient (see section 5.1):

- for improvement of haemostasis.

Assessment history

How useful was this page?

Add your rating